Management of NAFLD in primary care settings - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Liver International Year : 2022

Management of NAFLD in primary care settings


Non-alcoholic fatty liver disease (NAFLD) affects at least 25% of the general population and is an increasingly important cause of cirrhosis and hepatocellular carcinoma. Although it is the research focus of the hepatology field, it is clear that primary care physicians are seeing the majority of NAFLD patients and are in a pivotal position to provide quality care. In this article, we review the role of primary care in the management of NAFLD. NAFLD is common in patients with diabetes, obesity and other metabolic risk factors. Abdominal ultrasonography is the most commonly used method to diagnose fatty liver. Simple fibrosis scores have high negative predictive values in excluding advanced liver fibrosis and future liver-related events and can be used in primary care as initial evaluation. An abnormal result should be followed by subsequent workup or specialist referral. Primary care is the ideal setting to institute multidisciplinary care, especially the involvement of dietitians and physical activity trainers in lifestyle intervention, as well as initiating the discussion of bariatric surgery in patients with severe obesity. Although specific drug treatment for steatohepatitis would require a more precise diagnosis, metabolic drugs that improve both steatohepatitis and cardiovascular outcomes (e.g. glucagon-like peptide-1 receptor agonists) may be considered in patients with NAFLD.
Embargoed file
Embargoed file
Ne sera jamais visible

Dates and versions

inserm-04051853 , version 1 (30-03-2023)



Vincent W S Wong, Shira Zelber‐sagi, Kenneth Cusi, Patrizia Carrieri, Eugene Wright, et al.. Management of NAFLD in primary care settings. Liver International, 2022, 42 (11), pp.2377 - 2389. ⟨10.1111/liv.15404⟩. ⟨inserm-04051853⟩
22 View
0 Download



Gmail Facebook X LinkedIn More